Ready to play
Ready to play
The pharmaceutical industry sector in South Africa has been adversely affected, having lost over 2,500 jobs in the past 18 months due to competition from imported products and public procurement policies that favor cheaper medicines. This has led to a decline in the market share of local producers from 72% in 2008 to 28% in 2025 for HIV medications. Additionally, their share of tablet and capsule deals has fallen from 56% in 2014 to 18% in 2026, despite a price increase of only 1.47% at the start of 2026, which is below the inflation rate of 3.3%. The Ministry of Health defended its procurement strategy, while the President launched a task force to enhance the capabilities of the national pharmaceutical industry and reduce reliance on foreign imports.
Notice: This Is an AI-Generated Summary
Comments (0)